Dirk is a Senior Director of Medical Affairs at Taysha Gene Therapies, Europe. During the last 17 years in rare disease, he was engaged in different roles at Astellas Gene Therapies, Audentes Therapeutics, Ultragenyx, Pfizer and Encysive. He is well experienced in the pre-launch and launch of Orphan drugs and is strongly committed to research, innovation, and commercialization of biotech and pharmaceutical products.